Promote sweating and reducing subcutaneous fat, reduce lymphotoxin and deposit, and gift you a slim figure. 增加排汗及促进皮下脂肪的排除;减少淋巴毒素和沉积物,窈窕瘦身。
Relationship of the Lymphotoxin a Gene Polymorphism with Chronic Obstructive Pulmonary Disease 淋巴毒素A基因多态性与慢性阻塞性肺疾病的关系
Association of lymphotoxin-α polymorphisms with myocardial infarction: a Meta-analysis 淋巴毒素α基因多态性与心肌梗死关系的Meta分析
The Study of Relationship between Lymphotoxin-α and Acute Coronary Syndrome Pathogenesis 淋巴毒素α与急性冠脉综合征发病关系的研究
The Relationship of Genetic Polymorphisms of Lymphotoxin-α and Tumor Necrosis Factor-α with Acute Coronary Syndrome 淋巴细胞毒素-α基因C804A多态性、肿瘤坏死因子-α与急性冠脉综合征的关系
Study on the expression of lymphotoxin-β in SLE and the clinical correlation SLE中淋巴毒素β基因表达及相关性研究
Study on the expressions of lymphotoxin-β in lupus nephritis patients and correlational 狼疮性肾炎患者淋巴毒素-β表达及相关性研究
Construction of Combined Site-directed Random Mutation Libraries of Recombinant Human Lymphotoxin 重组人淋巴毒素随机点突变组合文库的构建
Construction of Recombinant Human Lymphotoxin Mutation Libraries and Receptor Affinity Screening 重组人淋巴毒素突变体库的构建及受体亲和筛选
Expression of Human Lymphotoxin Gene in CHO-DHFR-Cells 人淋巴毒素基因在中国仓鼠细胞中表达
Conclusion: Lymphotoxin α gene may play a role in relation to secretion of tumour necrosis factor α in Chinese patients with inflammatory bowel disease. 认为:中国人群炎症性肠病患者淋巴毒素α基因可能对肿瘤坏死因子α产量起一定作用。
Cloning and sequencing of cDNA of human lymphotoxin 人淋巴毒素cDNA克隆及顺序分析
Clinical Pharmacokinetic Trial of Intravenous Injection of Recombinant Human Lymphotoxin-α Derivative 注射用重组人淋巴毒素α衍生物的临床药代动力学研究
No Association of Lymphotoxin α Nco ⅰ and AspH ⅰ Gene Polymorphisms with Helicobacter Pylori Infection in Chinese Patients with Gastroduodenal Diseases 淋巴毒素αNcoⅠ、AspHⅠ基因多态性与胃十二指肠疾病幽门螺旋杆菌的感染无关
Expression of cDNA for human lymphotoxin in E.coli 人淋巴毒素cDNA在大肠杆菌表达的研究
To construct the combined site_directed random mutation library of recombinant human Lymphotoxin ( rhLT) for in vitro molecular evolution study, and to study the structure and function relationship. 构建重组人淋巴毒素(rhLT)随机点突变组合文库以进行体外分子进化及结构和功能的研究。
BACKGROUND& OBJECTIVE: Intravenous recombinant human lymphotoxin-α derivative ( rhLT α-Da) is a novel biological antitumor reagent developed in China. 背景与目的:注射用重组人淋巴毒素α衍生物(rhLTα-Da)是我国研制的一全新抗肿瘤生物制品。
High-cell-density Fermentation, Annealing and Purification of Recombinant Human Lymphotoxin alpha ( rhLT-α) in Escherichia coli 重组人淋巴毒素α的高密度发酵、复性和纯化
The effort to proceed molecular evolution study of lymphotoxin in vitro by phage display not only can be very useful for the following research involved in the relation between structure and function, but also provides potent tool for macromolecule drug development. 应用噬菌体展示技术对淋巴毒素进行体外进化研究的尝试,为下一步的蛋白质结构和功能研究提供了思路,可成为大分子药物开发的有效工具。
The antitumor activity of recombinant human lymphotoxin 重组人淋巴毒素抗肿瘤作用的研究
Analysis of Lymphotoxin-β Gene Transcription Level and Polymorphism in SLE Patients SLE患者淋巴毒素-β基因转录水平及多态性分析
Lymphotoxin A ( LTA) is an important for inflammatory mediator involved in regulating B, T lymphocytes in the immune regulation and local inflammatory response. 淋巴毒素A(LTA)是一种重要的炎症介质,参与调控B淋巴细胞、T淋巴细胞的免疫调控和局部炎症反应[6]。